146 related articles for article (PubMed ID: 16115489)
1. Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease.
Ziegler S; Kudlacek S; Luger A; Minar E
Atherosclerosis; 2005 Sep; 182(1):175-80. PubMed ID: 16115489
[TBL] [Abstract][Full Text] [Related]
2. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.
Gannagé-Yared MH; Fares F; Semaan M; Khalife S; Jambart S
Clin Endocrinol (Oxf); 2006 Jun; 64(6):652-8. PubMed ID: 16712667
[TBL] [Abstract][Full Text] [Related]
3. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C
Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction.
Crisafulli A; Micari A; Altavilla D; Saporito F; Sardella A; Passaniti M; Raffa S; D'anneo G; Lucà F; Mioni C; Arrigo F; Squadrito F
Clin Sci (Lond); 2005 Oct; 109(4):389-95. PubMed ID: 15926884
[TBL] [Abstract][Full Text] [Related]
5. Osteoprotegerin and RANKL in alcoholic liver cirrhosis.
Fábrega E; Orive A; García-Suarez C; García-Unzueta M; Antonio Amado J; Pons-Romero F
Liver Int; 2005 Apr; 25(2):305-10. PubMed ID: 15780054
[TBL] [Abstract][Full Text] [Related]
6. Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity.
Kim SM; Lee J; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
Clin Endocrinol (Oxf); 2005 Nov; 63(5):594-8. PubMed ID: 16268814
[TBL] [Abstract][Full Text] [Related]
7. High serum values of soluble CD154, IL-2 receptor, RANKL and osteoprotegerin in Langerhans cell histiocytosis.
Ishii R; Morimoto A; Ikushima S; Sugimoto T; Asami K; Bessho F; Kudo K; Tsunematu Y; Fujimoto J; Imashuku S
Pediatr Blood Cancer; 2006 Aug; 47(2):194-9. PubMed ID: 16358318
[TBL] [Abstract][Full Text] [Related]
8. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
9. Correlation of osteoprotegerin and sRANKL concentrations in serum and bone marrow of multiple myeloma patients.
Kraj M; Owczarska K; Sokołowska U; Centkowski P; Pogłód R; Kruk B
Arch Immunol Ther Exp (Warsz); 2005; 53(5):454-64. PubMed ID: 16314829
[TBL] [Abstract][Full Text] [Related]
10. Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.
Seminari E; Castagna A; Soldarini A; Galli L; Fusetti G; Dorigatti F; Hasson H; Danise A; Guffanti M; Lazzarin A; Rubinacci A
HIV Med; 2005 May; 6(3):145-50. PubMed ID: 15876279
[TBL] [Abstract][Full Text] [Related]
11. [The relationships between changes of serum osteoprotegerin, nuclear factor-kappa B ligand receptor activator, and age, menopause, bone biochemical markers and bone mineral densities in women aged 20 - 75].
Liu JM; Zhao HY; Ning G; Zhao YJ; Chen Y; Zhang LZ; Xu MY; Chen JL
Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):447-50. PubMed ID: 15312444
[TBL] [Abstract][Full Text] [Related]
12. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
García-Valdecasas-Campelo E; González-Reimers E; Santolaria-Fernández F; De la Vega-Prieto MJ; Milena-Abril A; Sánchez-Pérez MJ; Martínez-Riera A; Gómez-Rodríguez Mde L
Alcohol Alcohol; 2006; 41(3):261-6. PubMed ID: 16476762
[TBL] [Abstract][Full Text] [Related]
13. Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's disease.
Emanuele E; Peros E; Scioli GA; D'Angelo A; Olivieri C; Montagna L; Geroldi D
Int J Mol Med; 2004 Jun; 13(6):849-53. PubMed ID: 15138623
[TBL] [Abstract][Full Text] [Related]
14. Increased osteoprotegerin serum levels in men with coronary artery disease.
Schoppet M; Sattler AM; Schaefer JR; Herzum M; Maisch B; Hofbauer LC
J Clin Endocrinol Metab; 2003 Mar; 88(3):1024-8. PubMed ID: 12629080
[TBL] [Abstract][Full Text] [Related]
15. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand system in the early post-operative period of liver transplantation.
Fábrega E; Orive A; García-Unzueta M; Amado JA; Casafont F; Pons-Romero F
Clin Transplant; 2006; 20(3):383-8. PubMed ID: 16824158
[TBL] [Abstract][Full Text] [Related]
16. Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients.
Nitta K; Akiba T; Uchida K; Otsubo S; Takei T; Yumura W; Kabaya T; Nihei H
Nephrol Dial Transplant; 2004 Jul; 19(7):1886-9. PubMed ID: 15128884
[TBL] [Abstract][Full Text] [Related]
17. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Measurement and clinical role of OPG].
Sasaki N; Kusano E
Clin Calcium; 2006 Jun; 16(6):956-62. PubMed ID: 16751691
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
Simonini G; Masi L; Giani T; Piscitelli E; Cimaz R; Vierucci S; Brandi ML; Falcini F
J Rheumatol; 2005 Nov; 32(11):2233-8. PubMed ID: 16265708
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.
Magal I; Lebel E; Altarescu G; Itzchaki M; Rudensky B; Foldes AJ; Zimran A; Elstein D
Br J Haematol; 2006 Apr; 133(1):93-7. PubMed ID: 16512834
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury?
Masi L; Simonini G; Piscitelli E; Del Monte F; Giani T; Cimaz R; Vierucci S; Brandi ML; Falcini F
J Rheumatol; 2004 May; 31(5):986-91. PubMed ID: 15124262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]